Nano Nuclear Energy Inc. (NNE) | The Buildout — AI Infrastructure
The Verdict
Nano Nuclear Energy is developing a small modular microreactor, the KRONOS MMR, designed to be factory‑fabricated and deployed in groups to provide behind‑the‑meter baseload power for AI data centres. The company is also building an integrated nuclear fuel cycle, from enrichment to transportation, to support fleet deployment of its reactors.
| Market Cap | — |
| Revenue (TTM) | $0M |
| Net Cash | $566M |
| Earnings Beats | 6 of 7 |
| P/E (TTM) | — |
| EV/EBITDA (TTM) | — |
What We Like
- First mover: CPA accepted by the NRC — the first commercially‑ready microreactor to reach this milestone, triggering a ~12‑month review.
- Cash runway: $569M in liquid assets funds the estimated $300–350M first‑of‑a‑kind prototype, with a $900M shelf available.
- Revenue milestone: STS acquisition adds an operating nuclear transportation business; completed three DOE/NNSA missions within two days.
- Fuel flexibility: KRONOS can use LEU+ fuel that is commercially available today, while remaining HALEU‑compatible without further redesign.
- Pipeline building: BaRupOn feasibility study for up to 1 GW for a Texas AI campus completed; two major hyperscalers are evaluating the facility.
What We’re Watching
- NRC review: any delay beyond the ~12‑month window would push construction past mid‑2027.
- BaRupOn conversion: the project depends on hyperscaler commitments and third‑party financing; no binding power agreement has been signed.
- Cash burn rising: quarterly net loss widened by $2.7 million QoQ and expenses are expected to climb as long‑lead procurement begins.
- Competition: Oklo is constructing test reactors now and has a 1.2 GW Meta deal, setting a faster operational timeline.
The thesis is strengthening: the company has delivered on every near‑term milestone — CPA acceptance, STS acquisition, and new partner MOUs — while preserving a strong cash position. The key open question is whether it can convert pipeline interest into binding power‑purchase agreements before mounting cash burn forces dilution.
Earnings Beat
Nano Nuclear reported no revenue for its fiscal Q2 (ending March 31, 2026), as the core reactor business remains pre‑revenue. Net loss widened to $9.2 million from $6.5 million in the prior quarter, driven by higher headcount and licensing expenses. Cash and short‑term investments stood at $569 million.
| Metric | Q2 FY2026 | Q1 FY2026 | Q2 FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $0M | $0M | $0M | — |
| Gross margin | — | — | — | — |
| EBITDA | −$14M | −$11M | −$22M | −38.8% |
| EPS | $-0.18 | $-0.13 | $-0.57 | −68.9% |
Nano became one of only a handful of Generation 4 advanced reactor developers to reach this stage and the first commercially ready microreactor to submit a CPA to the NRC.— Jiang Yu, Founder and Chairman, Q2 FY2026 call, May 14, 2026
Management tone: Management's commentary shifted markedly from forward‑looking pledges to specific delivered milestones, led by the CPA acceptance, the completed BaRupOn feasibility study, and the telegraphed STS acquisition that closed shortly after the call.
Management Guidance
Management did not provide quantified current‑year revenue or earnings guidance. It stated that operating expenses are expected to trend higher as the team scales and long‑lead procurement begins, and that the company is evaluating non‑dilutive funding opportunities but has no quantified amounts yet.
Trajectory
Nano Nuclear’s net loss widened to $9.2 million as headcount and regulatory spending grew, consistent with management’s forecast of rising expenses. With no reactor revenue expected before 2030, the quarterly loss is set to increase further as the company negotiates long‑lead component contracts and builds out its demonstration facilities. The recent STS acquisition will begin contributing revenue from the next quarter, but its scale relative to the overall cash burn is not yet disclosed.
The Model
The model projects FY+1 revenue of $3 million and EBITDA of -$55 million, driven by the new STS transportation business and initial consulting fees, while reactor‑related costs keep losses large. FY+2 sees revenue rise to $10 million, but EBITDA widens to -$69 million as development spending accelerates ahead of the 2027 construction start. Strong dispersion across the five independent runs (revenue spread 342% in FY+1 and 400% in FY+2) reflects extreme early‑stage uncertainty.
| Metric | FY2025 | Next FY (E) | Following FY (E) |
|---|---|---|---|
| Revenue | $0M | $3M | $10M |
| YoY Growth | — | — | +233.3% |
| EBITDA | −$46M | −$55M | −$69M |
| EBITDA Margin | — | -1324.3% | -512.5% |
Projections are the median of 5 independent model runs.
Management did not provide quantified current‑year revenue or earnings guidance. It stated that operating expenses are expected to trend higher as the team scales and long‑lead procurement begins, and that the company is evaluating non‑dilutive funding opportunities but has no quantified amounts yet.
What Could Go Right — and Wrong
- NRC grants the construction permit on or ahead of schedule, enabling construction by mid‑2027.
- BaRupOn signs a binding power purchase agreement with a hyperscaler tenant, converting the AI project from speculative to concrete.
- A multi‑unit order from the DOE or a large industrial partner provides revenue visibility and accelerates manufacturing scale‑up.
- Additional fuel‑cycle acquisitions close in 2026, increasing near‑term revenue and supply control.
- The NRC’s Part 57 framework is finalised, materially expediting microreactor fleet licensing for NNE’s standardised design.
- NRC review extends beyond 12 months or rejects the CPA, delaying the entire timeline and eroding the first‑mover advantage.
- BaRupOn relationship collapses or hyperscalers select a competing power solution, removing the primary commercial catalyst.
- FOAK cost balloons well beyond $350M, forcing a dilutive capital raise or slowing the project.
- Oklo or another competitor reaches commercial operation years ahead, securing early‑adopter AI data centre customers.
- AI electricity demand growth disappoints, reducing the need for off‑grid nuclear power.
Looking Ahead
Over the next twelve months, investors will watch the NRC’s progress on the UIUC construction permit, the potential conversion of the BaRupOn project into a binding agreement, and the integration of STS. Management has also guided for additional commercial announcements and fuel‑cycle M&A, which would build the pipeline beyond BaRupOn. Operating expenses are expected to climb as long‑lead procurement begins, testing the company’s cash discipline.
- By mid‑2027NRC construction permit decision — 12‑month review of the UIUC CPA concludes; approval triggers construction start mid‑ to late‑2027.
- 2026Fuel‑cycle M&A — Acquisition of a conversion facility or enrichment stake to deepen vertical integration.
- 2026New commercial partnerships — Additional MOUs or offtake agreements from the data‑centre and industrial pipeline.
- 2026–2027DS Dansuk manufacturing plan — Decision on a reactor core manufacturing facility in South Korea.
- Mid‑ to late‑2027UIUC construction launch — Site excavation and preparation begin for the first KRONOS prototype.
Financials
Annual Summary
| Metric | FY2025 | TTM |
|---|---|---|
| Revenue | $0M | $0M |
| Gross Margin | — | — |
| EBITDA | −$46M | −$78M |
| EBITDA Margin | — | — |
| Net Income | −$40M | −$31M |
| Free Cash Flow | −$28M | −$54M |
| Net Cash | — | — |
Key Ratios (Trailing)
- P/E TTM—
- EV/EBITDA TTM—
- EV/Revenue TTM—
- Price/FCF TTM—
- ROIC-120.6%
The Company
Nano Nuclear Energy’s central technology is the KRONOS MMR, a 15 MWe high‑temperature gas‑cooled microreactor fuelled by TRISO particles. It is designed to be factory‑built, transported to site, and grouped in multiples to provide up to a gigawatt or more of behind‑the‑meter baseload power — a configuration that directly targets the round‑the‑clock demands of AI data centres. The company complements the reactor with an in‑house fuel cycle that spans enrichment, fuel fabrication, and transportation, aiming to control the supply chain for fleet deployment.
This is essentially a pre‑commercial R&D company; its first full‑scale prototype is being co‑developed with the University of Illinois Urbana‑Champaign under an NRC Part 50 construction permit application. Meanwhile, the company has used its cash balance to acquire an operating nuclear transportation business, STS, giving it revenue today while reactor development continues. Manufacturing and factory plans remain in the early planning phases, with a potential reactor core facility under discussion with South Korea’s DS Dansuk. The company operates from facilities in New York, Oak Ridge, Westchester, and Oak Brook, with demonstration and assembly spaces backing the KRONOS effort.
Business Segments
Competitive Landscape
Nano Nuclear operates in a crowded advanced‑reactor field that includes Oklo, TerraPower, X‑Energy, and others. Management differentiates the company by its Part 50 CPA first‑mover status and its integrated fuel‑cycle platform. Competitors such as Oklo have faster construction timelines, while other peers rely on alternative licensing pathways or lack the vertical integration NNE is building.
- OkloConstructing test reactors now; target criticality July 2026; 1.2 GW Meta deal provides a large customer commitment.
- TerraPowerAdvanced sodium‑cooled fast reactor; backed by Bill Gates. Named in filings.
- X‑EnergyHTGR microreactor; direct technology peer. Named in filings.
- GE HitachiBWRX‑300 SMR; competes for data centre baseload. Named in filings.
- KairosFluoride salt‑cooled high‑temperature reactor. Named in filings.
Supply Chain
Nano Nuclear sits between fuel suppliers and end‑users, building an integrated chain from uranium sourcing and enrichment through reactor manufacturing to transportation and deployment. Its acquisition of STS gives it a direct logistics hand within the DOE/NNSA mission set.